Yu-Hsin Chen1, Szu-Chun Hung, Der-Cherng Tarng. 1. Department of Medicine, Taipei Veterans General Hospital, Su-Ao Branch, Yilan, Taiwan;, †Faculty of Medicine and, ‖Department and Institute of Physiology, National Yang-Ming University, Taipei, Taiwan;, ‡Division of Nephrology, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan, §Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Abstract
BACKGROUND AND OBJECTIVES: Persistent inflammation and oxidative stress play a pathogenic role in the high cardiovascular morbidity and mortality of hemodialysis patients. Heme oxygenase-1 is considered to have anti-inflammatory and antioxidant properties. This study assessed the association between the length of guanosine thymidine dinucleotide repeats in the heme oxygenase-1 gene microsatellite promoter and cardiovascular events and mortality among hemodialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Study participants were recruited from October 1, 2006 to December 31, 2006. The allelic frequencies of the length of guanosine thymidine dinucleotide repeats (the S allele represents shorter [<27] repeats, and the L allele represents longer [≥ 27] repeats) in the heme oxygenase-1 gene promoter were analyzed in 1080 unrelated chronic hemodialysis patients and 365 healthy controls for distribution comparison. Cardiovascular events and mortality were the study outcomes, and the hemodialysis patients were followed until June 30, 2011. RESULTS: The genotype proportions were 20.6%, 48.8%, and 30.6% for S/S, S/L, and L/L, respectively, in the hemodialysis patients and comparable with those proportions in healthy controls. The patients with the L/L genotype had significantly higher baseline serum high-sensitivity C-reactive protein and malondialdehyde levels than the patients with the S/S or S/L genotypes. During a median follow-up of 50 months, 307 patients died. A Kaplan-Meier survival analysis showed the highest cardiovascular events and all-cause mortality in patients with the L/L genotype. The adjusted hazard ratios (95% confidence intervals) for each L allele in additive model were 1.42 (1.20 to 1.67 [P<0.001]) for cardiovascular events and 1.19 (1.01 to 1.40 [P=0.03]) for all-cause mortality. CONCLUSIONS: Chronic hemodialysis patients with longer lengths of guanosine thymidine dinucleotide repeats in the heme oxygenase-1 gene promoter exhibit higher inflammation and oxidative stress. These patients have higher risk of long-term cardiovascular events and mortality.
BACKGROUND AND OBJECTIVES: Persistent inflammation and oxidative stress play a pathogenic role in the high cardiovascular morbidity and mortality of hemodialysis patients. Heme oxygenase-1 is considered to have anti-inflammatory and antioxidant properties. This study assessed the association between the length of guanosine thymidine dinucleotide repeats in the heme oxygenase-1 gene microsatellite promoter and cardiovascular events and mortality among hemodialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Study participants were recruited from October 1, 2006 to December 31, 2006. The allelic frequencies of the length of guanosine thymidine dinucleotide repeats (the S allele represents shorter [<27] repeats, and the L allele represents longer [≥ 27] repeats) in the heme oxygenase-1 gene promoter were analyzed in 1080 unrelated chronic hemodialysis patients and 365 healthy controls for distribution comparison. Cardiovascular events and mortality were the study outcomes, and the hemodialysis patients were followed until June 30, 2011. RESULTS: The genotype proportions were 20.6%, 48.8%, and 30.6% for S/S, S/L, and L/L, respectively, in the hemodialysis patients and comparable with those proportions in healthy controls. The patients with the L/L genotype had significantly higher baseline serum high-sensitivity C-reactive protein and malondialdehyde levels than the patients with the S/S or S/L genotypes. During a median follow-up of 50 months, 307 patients died. A Kaplan-Meier survival analysis showed the highest cardiovascular events and all-cause mortality in patients with the L/L genotype. The adjusted hazard ratios (95% confidence intervals) for each L allele in additive model were 1.42 (1.20 to 1.67 [P<0.001]) for cardiovascular events and 1.19 (1.01 to 1.40 [P=0.03]) for all-cause mortality. CONCLUSIONS: Chronic hemodialysis patients with longer lengths of guanosine thymidine dinucleotide repeats in the heme oxygenase-1 gene promoter exhibit higher inflammation and oxidative stress. These patients have higher risk of long-term cardiovascular events and mortality.
Authors: G Clermont; S Lecour; J Lahet; P Siohan; C Vergely; D Chevet; G Rifle; L Rochette Journal: Cardiovasc Res Date: 2000-08-18 Impact factor: 10.787
Authors: Martin Schillinger; Markus Exner; Erich Minar; Wolfgang Mlekusch; Marcus Müllner; Christine Mannhalter; Fritz H Bach; Oswald Wagner Journal: J Am Coll Cardiol Date: 2004-03-17 Impact factor: 24.094
Authors: David E Leaf; Simon C Body; Jochen D Muehlschlegel; Gearoid M McMahon; Peter Lichtner; Charles D Collard; Stanton K Shernan; Amanda A Fox; Sushrut S Waikar Journal: J Am Soc Nephrol Date: 2016-06-02 Impact factor: 10.121
Authors: Raimund Pechlaner; Peter Willeit; Monika Summerer; Peter Santer; Georg Egger; Florian Kronenberg; Egon Demetz; Günter Weiss; Sotirios Tsimikas; Joseph L Witztum; Karin Willeit; Bernhard Iglseder; Bernhard Paulweber; Lyudmyla Kedenko; Margot Haun; Christa Meisinger; Christian Gieger; Martina Müller-Nurasyid; Annette Peters; Johann Willeit; Stefan Kiechl Journal: Arterioscler Thromb Vasc Biol Date: 2014-10-30 Impact factor: 8.311